Skip to Main Content

An approved gene therapy restores vision in children born with a rare form of blindness. There are other gene therapies advancing through clinical trials that could one day treat — and potentially cure — people suffering from devastating diseases like sickle cell, hemophilia, and Duchenne muscular dystrophy, among others.

Overactive bladder is bothersome, but it is most definitely not a devastating disease. Yet Tuesday, the biotech firm Urovant Sciences announced plans to pursue clinical development of a gene therapy to treat people who have this troubling but by no means life-threatening condition.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.